Get started
Author

Yan Zhu

Observed names: Y Zhu, Y. Zhu
Observed institutions: University of Maryland, Baltimore, Sun Yat-sen University, Beijing University of Chinese Medicine, Shanghai Jiao Tong University, Chinese Academy of Sciences, Shanghai Chest Hospital, West China Hospital of Sichuan University, Cancer Hospital of Shantou University Medical College, Peking University Cancer Hospital, Johnson & Johnson (Singapore), Affiliated Hospital of Qingdao University, Beijing Hospital, Qingdao Municipal Hospital, The Affiliated Yongchuan Hospital of Chongqing Medical University, Peking University First Hospital, Tianjin Institute of Industrial Biotechnology, China Academy of Chinese Medical Sciences, Xiangya Hospital Central South University, Luoyang Orthopedic-Traumatological Hospital of Henan Province, Adelphi University, Yangzhou University, Nanjing University
ORCID: 0000-0002-6554-6798
Observed ORCID: 0000-0002-6554-6798
OpenAlex ID: A5103129546
Postoperative Systemic Immune-Inflammation Index (SII): A Superior Prognostic Factor of Endometrial Cancer
2021 · Yihong Huang, Yu Chen, et al. · Frontiers in Surgery · 78
PDF
Subunits of ARID1 serve as novel biomarkers for the sensitivity to immune checkpoint inhibitors and prognosis of advanced non-small cell lung cancer
2020 · Dantong Sun, Lu Tian, et al. · Molecular Medicine · 60
PDF
Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis
2021 · Dantong Sun, Yan Zhu, et al. · Cellular Oncology · 50
Pan-cancer analysis of ARID family members as novel biomarkers for immune checkpoint inhibitor therapy
2022 · Yan Zhu, Chun Yan, et al. · Cancer Biology & Therapy · 46
Primary resistance to first-generation EGFR-TKIs induced by MDM2 amplification in NSCLC
2020 · Dantong Sun, Yan Zhu, et al. · Molecular Medicine · 38
PDF
Pembrolizumab monotherapy or combination therapy for bone metastases in advanced non-small cell lung cancer: a real-world retrospective study
2022 · Huiping Qiang, Yuqiong Lei, et al. · Translational Lung Cancer Research · 31
PDF
Smell cancer by machine learning-assisted peptide/MXene bioelectronic array
2024 · Jiawang Hu, Nanlin Hu, et al. · Biosensors and Bioelectronics · 24
Prognostic Value of Inflammation-Based Markers in Advanced or Metastatic Neuroendocrine Tumours
2019 · J. Zou, Q. Li, et al. · Current Oncology · 23
PDF
Epidemiology of elevated blood pressure and associated risk factors in Chinese children: the SNEC study
2015 · Y Zhou, Z Qian, et al. · Journal of Human Hypertension · 22
SVIL promotes ovarian cancer progression and epithelial-mesenchymal transition under hypoxic conditions through the TGF-β/Smad pathway
2024 · Dongfang Dai, Congzhu Li, et al. · Gynecologic Oncology · 11
Transcriptomic investigations of polymyxins and colistin/sulbactam combination against carbapenem-resistant Acinetobacter baumannii
2024 · Xingchen Bian, Mengyao Li, et al. · Computational and Structural Biotechnology Journal · 11
Concurrent Refractory Atopic Dermatitis and Generalized Vitiligo Successfully Treated with Abrocitinib: A Case Report
2024 · Xinyi Shao, Xingyu Pan, et al. · Journal of Asthma and Allergy · 7
Neoadjuvant immunology therapy in patients with non-small cell lung cancer and chronic obstructive pulmonary disease
2024 · Qing Chang, Jiaqi Li, et al. · Journal of Thoracic Disease · 5
Ontology of clinical practice guidelines for Integrated Traditional Chinese and Western Medicine
2024 · Yongbo Wang, Xiangying Ren, et al. · Journal of Evidence-Based Medicine · 4
Clinical Efficacy of Cognitive Behavioral Therapy Combined with Pinaverium Bromide Tablets on Irritable Bowel Syndrome
2023 · Quanxi Liu, Yan Zhu, et al. · Pakistan Journal of Medical Sciences · 4
PDF
Effectiveness and Safety of the Traditional Chinese Medicine Treatment (HuoxueHuayu Therapy) for Malignant Tumors: A Systematic Review and Meta-Analysis
2022 · Zehui Chen, An Wang, et al. · Evidence-based Complementary and Alternative Medicine · 4
PDF
The predictive value of routine laboratory tests for colorectal polyps: a retrospective study
2022 · Xinyi Feng, Xiuping Jiao, et al. · Journal of Gastrointestinal Oncology · 4
PDF
Clinical and VASARI Features to Predict CDKN2A/B Homozygous Deletion in IDH -Mutant Astrocytomas: A Multicenter Study
2025 · Huiquan Yang, Zhengyang Zhu, et al. · American Journal of Neuroradiology · 3
Pooled Efficacy and Safety of Teclistamab in 217 Patients with Triple-Class Exposed Relapsed/Refractory Multiple Myeloma from 3 Registrational Clinical Studies
2024 · Thomas G Martin, María-Victoria Mateos, et al. · Blood · 2
Myocyte-specific enhancer factor 2D promotes tumorigenesis and progression in tongue squamous cell carcinoma.
2020 · Yang Liu, Wenjun Yu, et al. · PubMed · 2
[Detection of p53 gene alteration in sputum sample and its implications in early diagnosis of lung cancer].
2001 · B Wang, L Li, et al. · PubMed · 2
Factors of treatment success in psychotherapy: a within-therapist analysis of early session processes
2025 · Yan Zhu, Mark J. Hilsenroth · Research in Psychotherapy Psychopathology Process and Outcome · 1
PDF
27P Concurrent chemoradiotherapy and immunotherapy for locally advanced cervical cancer: A cost-effectiveness analysis based on the KEYNOTE-A18 trial
2024 · K. Liu, Y. Zhu, et al. · ESMO Open · 1
B7-H4 correlates with clinical outcome and immunotherapeutic benefit in muscle-invasive bladder cancer
2024 · Y. Zhu, Z. Liu, et al. · European Urology · 1
[Posterior cervical pedicle screw rod short-segment internal fixation for the treatment of atlantoaxial fracture and dislocation].
2023 · Hong-Xing Zhang, Yan Zhu, et al. · PubMed · 1
Works count: 39
Citation count: 436
H-index: 11
I10-index: 11
Year
Topic
Type